TK Rucker @rucktech

🫡 have the ability to reverse your position if something changes, its what we did here on $NVDA @ttvresearch @traderTVLIVE

🔥 Here’s is my🔥 #stickynote for June 22, 2026: 📈 Market Insight: AI leaders remain in focus as traders look for signs of rotation and exhaustion. Watching mega-cap tech for weakness while looking for opportunities in names showing relative strength. 🎯 Trade Ideas: 🔴 $GOOGL SHORT $364-$365 • Looking for early weakness after losing momentum • Watching for continued selling if buyers fail to reclaim levels • Recent AI narrative losing some steam vs other AI leaders 🟢 $IBIT LONG $36.25 • Looking for a bounce after recent weakness • Watching BTC strength for confirmation • Key level: 200-period SMA on the 1-minute chart 🟢 $MRVL LONG $310 • Looking for a dip into support • Strong AI deman story remains intact • Watching for buyers to step in after recent pullback False move down on Thursday in this name due to rebalancing, should hold the pre market lows here. ⚠️ Stay patient and let the setup come to you. Strong traders manage risk first — the opportunity comes from execution. #stocks #trading #investing #daytrading #stickynote #stockmarket #wallstreet #options #bitcoin #crypto #AI #GOOGL #IBIT #MU #nasdaq #spy #qqq @tradertvlive @ttvresearch

The next setup is hiding in a biotech stock that's been flat for years. Here's why: - The business is growing while the stock is flat - Institutions are likely to accumulate during the dead zone - A near-term event like earnings, an FDA approval, or a spinoff is approaching that hasn't been priced in. When all three line up, the stock hasn't caught up to the business yet. ADPT fits all three signs. I'd suggest putting it on your watch list and wait.

Felix Prehn 🐶 @felixprehn

5 days ago

There's a $17 stock I believe can 10x by 2030. It's down 87% from its peak in 2021, and its stock chart has gone sideways for years while the business became more competitive. This is exactly what to look for in high potential, small-cap stocks. Here's the ticker:🧵

29 43 303 227K 451

IN 1986 MIT FILMED A LECTURE THAT OPENS BY TELLING YOU COMPUTER SCIENCE IS NOT A SCIENCE AND HAS ALMOST NOTHING TO DO WITH COMPUTERS 72 minutes from Hal Abelson and Gerald Sussman, the lecture an entire generation of engineers calls the one that rewired how they think. -> The line that lands: computer science is about computers the way astronomy is about telescopes. The tool was never the point. The real subject was always one thing -- controlling complexity. Everything else is detail. Forty years later it reads like a prophecy. AI writes the syntax now. What's left is exactly what they taught: taming complexity nobody can hold in their head. The language was never the skill -> the thinking was. This is where you learn it. Most people chase the newest framework. The ones who watched this think on a level frameworks can't touch. Bookmark & Watch today it, this one's a legend ↓

slash1s @slash1sol

7 days ago

A DEVELOPER PROVED THAT MOST OF THE CLASSES YOU WRITE SHOULD NEVER HAVE BEEN CLASSES AT ALL 27 minutes from Jack Diederich, a Python core developer, on how much of your code is just a function wearing a costume. -> The moment it lands, the rule is brutal: if a class has two

36 36 329 264K 477

People don't realize that we share this planet with the largest creature to ever exist in the history of Earth. The blue whale is so massive that its body operates on a scale almost impossible to picture. The heart of a blue whale is about the size of a small car.

A case reported in BMJ Case Reports describes a 61-year-old woman who was initially believed to have dementia after a five-year decline in her mental health and behaviour. She developed severe confusion, hallucinations, seizures, and marked personality changes, which included distressing behaviour such as speaking to unseen figures and acting inappropriately in public. Early brain scans and neurological tests did not show the usual signs of degenerative dementia, so she was treated symptomatically, but her condition continued to worsen. When she was later assessed by psychiatry specialists in Lisbon, blood tests revealed a severe vitamin B12 deficiency. This had led to pernicious anaemia, a condition where the body cannot absorb enough B12. Vitamin B12 is essential for healthy nerve function and the maintenance of the myelin sheath, the protective coating around nerves. Because of this deficiency, her nervous system had been significantly affected, producing symptoms that closely mimicked dementia and epilepsy. Once she began B12 injections and appropriate medical treatment, her condition improved dramatically. Over time, her hallucinations resolved, her thinking cleared, and she regained independence in daily life. Vitamin B12 deficiency is known to cause neurological and psychiatric symptoms in some cases, and while severe presentations like this are uncommon, doctors stress the importance of checking for reversible causes when patients show signs of cognitive decline because, in some situations, treatment can lead to major or even full recovery.

BREAKING: I am going to PROVE SELLING OPTIONS is SUPERIOR on $SPY for a LIVING 10 parts on X spaces NO CHARGE Sell Puts = Income Leaps = 10X Multi Baggers I have over 90% win rate selling OTM options All you need to do is drop a 👍and see my guide below class is in SESSION!

A Japanese immunologist spent 20 years proving that the chemicals trees release into the air walk into your bloodstream, hunt down your stress hormones, and arm your immune system in ways no therapist or pharmaceutical has ever matched, and most of the data has been sitting in Japanese medical journals for two decades waiting to be translated. His name is Qing Li. He is a clinical professor at Nippon Medical School in Tokyo and the president of the Japanese Society of Forest Medicine. The Japanese government has been funding his research since 2004, and the body of work he has produced is the reason forest bathing is now an officially prescribed clinical therapy in Japan and Korea. The story actually starts in 1982, when the Japanese Ministry of Agriculture, Forestry and Fisheries coined the term shinrin-yoku to describe the practice of slow, mindful walking in a forest. They did it for a practical reason. Japan was urbanizing fast, stress-related illness was climbing, and the country had thousands of square kilometers of forest sitting unused. The idea was to give people a reason to walk into the trees... They had no idea what was actually happening to the human body during those walks until Qing Li ran the first proper experiment in 2005. He took twelve healthy adult men on a three-day, two-night trip to a forest park. They walked for a few hours each day. Nothing strenuous. No prescribed routes or breathing exercises. They simply walked slowly through the trees, breathing the air, looking at the forest. Li drew blood and urine samples before the trip, on the second day, on the third day, on day seven after returning home, and again on day thirty. The numbers that came back from the lab were not what anyone expected. The activity of a specific type of immune cell called the natural killer cell, which is the cell your body uses to hunt down cancer cells and virus-infected cells before they can spread, had jumped by roughly 50 percent during the forest trip. The actual number of natural killer cells circulating in the bloodstream had increased significantly. Three different anti-cancer proteins that those cells produce, called perforin, granzymes, and granulysin, had all risen sharply. And the effect did not disappear when the men went home. The immune boost was still measurable on day seven and was still partially present on day thirty. Two hours a day in a forest had upgraded the immune system for a full month. Li ran the same experiment with women a year later and found nearly identical results. Then he ran it with a control group who took a three-day trip through an urban area with the same amount of walking, the same hotel quality, and the same diet. The urban group showed no measurable change in natural killer cell activity at all. The forest was doing the work, not the vacation. The mechanism turned out to be a class of airborne molecules called phytoncides. Trees produce these compounds to defend themselves against insects, bacteria, and fungi. Pine, cedar, oak, and cypress trees release them in particularly large amounts, especially in warmer weather and after rainfall. When you walk through a forest, you are inhaling those molecules into your lungs and absorbing them through your skin, and once inside your body they appear to directly stimulate the production and activity of the very immune cells Li was measuring in his lab. Roughly 50 percent of the health benefit of a forest walk, according to Li's data, comes from the chemistry of the air itself. The other half comes from what the forest is doing to your nervous system. This is where it stops being only about the immune system and starts being about stress. A separate Japanese research team measured cortisol, the body's main stress hormone, in 84 participants across 35 different forest sites. They drew samples before and after a 30-minute walk in each forest and compared them to control walks in matched urban environments. The cortisol levels of the people who walked in the forest were lower than the cortisol levels of the people who walked in the city by a significant margin. Their heart rates were lower. Their blood pressure was lower. The activity of their parasympathetic nervous system, which is the part responsible for rest and recovery, had gone up. The activity of their sympathetic nervous system, which is the part that drives fight or flight, had gone down. Then a researcher at the University of Michigan named MaryCarol Hunter ran the cleanest version of this experiment ever done. She recruited participants from a city and told them to take a nature pill three times a week for eight weeks. They were free to choose the time, the place, and the duration of the nature experience, as long as it was outside, in daylight, and free of phones, conversations, and aerobic exercise. They sent her saliva samples before and after each session so she could measure cortisol changes accurately and rule out the normal daily drop in stress hormones that happens to everyone. The result was that participants experienced a 21.3 percent drop in cortisol per hour spent in nature, with the biggest payoff happening between minutes 20 and 30 of the walk. After that, the cortisol kept dropping, but more slowly. The threshold dose for measurable stress relief was just 20 minutes outside in something that looked and felt like nature. What none of this means is that nature is a substitute for therapy or for medication when someone genuinely needs them. Therapy treats different things than a walk does, and Li himself has been careful in interviews to call forest bathing a complementary intervention rather than a replacement for clinical care. But what the research has settled is that the human body has a physiological response to being among trees that operates on the same biological systems modern medicine is trying to reach with drugs and clinical protocols, and that response is fast, measurable, and free. The strangest part of Li's work is the implication he keeps repeating in interviews. The average person now spends more than 90 percent of their life indoors. Their cortisol stays elevated. Their natural killer cells stay sluggish. Their parasympathetic nervous system rarely gets a chance to take over. The system that was tuned by millions of years of life under a canopy of trees is being asked to run permanently inside a box made of drywall and screens. Your body has not forgotten what it is supposed to do in a forest. It is waiting for you to walk into one.

He created a device that lets paralyzed individuals control phones, tablets, and computers with only their tongue. Created by MIT-trained engineer Tomás Vega, the device sits on the roof of the mouth and works like a wireless trackpad.

"Twisted Chrysanthemum Joint," a Japanese woodworking technique that interlocks wood pieces without nails or glue

When $SPY crashes 10%-20% this summer, I'd BUY ONLY bottleneck AI stocks. Without them there is no AI: $MU — Micron Technology Current: ~$879 | Buy Zone: $680–$700 HBM demand floor, prior ATH breakout retest, massive volume base $NVDA — NVIDIA Current: ~$200 | Buy Zone: $165–$180 200-day MA confluence, prior multi-month consolidation base reclaim $AVGO — Broadcom Current: ~$372 | Buy Zone: $320–$330 Custom ASIC demand floor, prior breakout level acting as support $MRVL — Marvell Technology Current: ~$245 | Buy Zone: $180–$200 S&P 500 inclusion tailwind, optical interconnect breakout retrace zone $ASML — ASML Holding Current: ~$1735 | Buy Zone: $1300–$1400 EUV monopoly moat, prior breakout ceiling flipped to support $AMAT — Applied Materials Current: ~$489 | Buy Zone: $390–$400 Chipmaking equipment leader, prior resistance turned demand zone $TSM — TSMC Current: ~$407 | Buy Zone: $350–$360 Foundry monopoly, 30% YoY revenue surge, institutional demand base $ANET — Arista Networks Current: ~$149 | Buy Zone: $125–$135 AI networking leadership, demand cluster at prior consolidation zone $CIEN — Ciena Corp Current: ~$429 | Buy Zone: $300–$320 Optical supply crunch through 2029, post-earnings gap fill support zone $LITE — Lumentum Current: ~$835 | Buy Zone: $600–$700 800G/1.6T backlog exploding, $1,000 psychological level holds as base $COHR — Coherent Corp Current: ~$402 | Buy Zone: $340–$360 NVDA $2B investment partner, indium phosphide ramp ahead of schedule $AAOI — Applied Optoelectronics Current: ~$174 | Buy Zone: $100–$120 800G hyperscale shipments just began, prior breakout base — high beta $VRT — Vertiv Holdings Current: ~$280 | Buy Zone: $230–$240 Liquid cooling backbone, ATH pullback to Q4 2025 breakout base level $NBIS — Nebius Group Current: ~$218 | Buy Zone: $160–$170 $46B Microsoft + Meta contracts, 684% revenue growth, EMA200 support $CRWV — CoreWeave Current: ~$95 | Buy Zone: $70–$80 $99.4B revenue backlog, near 52-week lows, high beta AI cloud floor $IREN — Iris Energy Current: ~$55 | Buy Zone: $30–$35 5GW NVDA partnership, $3.65B financing closed, renewable GPU compute ♻️ RESHARE this post and make 1 comment, I'll DM you my top 3 to get next week (sell off will continue more this week).

Dallol is an otherworldly place in Ethiopia’s Danakil Depression. It is one of the hottest places on Earth, with temperatures around 35–41°C all year. The area has bright green and yellow acidic pools with a pH close to zero, making it extremely harsh for life. 📹 visitethiopiaa

🚨 FIRST-EVER BRAIN REPAIR FOR PARKINSON'S? Japan has approved the world's first stem cell therapy for Parkinson’s disease. Scientists create new dopamine-producing brain cells in the lab and implant them into patients' brains to replace damaged cells. In early trials, patients showed improvements and brain scans confirmed the new cells were working. For millions living with Parkinson’s, this could be the beginning of a new era of brain repair. Source:
Sawamoto, N., et al. Nature. Kyoto University Center for iPS Cell Research and Application (CiRA); Sumitomo Pharma; Japan Ministry of Health.

The stunning reflective properties of a cutlassfish skin

We were joined in the studio by @ericjackson, veteran tech investor and founder of @EMJCapital, to discuss how everyday retail investors are leveraging modern technology to challenge traditional Wall Street narratives. @ttvresearch Check out the full conversation below! 👇

There is a forest in China made of stone. The Stone Forest (Shilin) in Yunnan province is an extraordinary landscape where thousands of towering limestone pillars rise from the ground like a petrified woodland, some reaching heights of 20 to 50 meters. Approximately 270 million years ago, this area was a shallow tropical seabed where thick layers of limestone formed from marine life. Tectonic uplift later exposed the rock, and over millions of years, mildly acidic rainwater carved the stone through a slow dissolution process known as karstification. The result is one of the world’s most spectacular examples of pinnacle karst topography a surreal “forest” of jagged, majestic stone formations

The market just handed you a gift 🎁 Names I’m watching on the dip: 🔴 $AAOI — photonics & AI fiber, up 282% YTD but pulled back hard 🔴 $MRVL — Jensen Huang called it “next trillion-dollar company.” Dip = opportunity 🔴 $NBIS — AI cloud infrastructure king 🔴 $RKLB — Space economy leader 🔴 $FLNC $ONDS $SIVE — high risk, high reward setups Dips don’t last forever.

$SPY crashed 3% in 1 day and everyone panicked. It's going to crash at least 10% soon. I'm adding these gems for 10x swing play: (stocks returns yesterday vs past year) 1. $AMD: -2.5% | +315% AI data center revenue +57% YoY. MI450 ramp begins. 2. $INTC: -3.9% | +466% Turnaround trade. AI server CPUs finally printing real numbers. 3. $SNDK: -1.4% | +4,490% NAND supply squeeze. No one saw this coming. Everyone missed it. 4. $ARM: -4.5% | +293% Every AI chip runs on ARM. Royalty flywheel just getting started. 5. $TSLA: -7.7% | +43% Robotaxi, humanoid, energy. Next decade belongs to full autonomy. 6. $BE: -9.5% | +1,273% Fuel cells power AI data centers. Oracle deal changes the growth curve. 7. $NOW: -5.0% | -39% AI workflow automation sleeper. Dip is the setup before the re-rate. 8. $ORCL: -6.4% | +64% Cloud AI contracts printing. $345 high shows the ceiling hasn't been found. 9. $NVDA: -4.1% | +49% Hyperscalers have no alternative. Jensen's decade is just beginning. 10. $AAOI: -12.5% | +1,093% 800G transceivers. AI optical backbone play hiding in plain sight. 11. $MRVL: -7.5% | +377% Jensen said it. Next trillion-dollar company. Custom ASICs win the race. 12. $HPE: -6.8% | +96% AI server demand exploding. Q2 blowout. Old tech, new AI hardware story. 13. $DELL: -3.0% | +329% AI PC + server supercycle. Jim Cramer says it's Dell's decade. Hard to argue. 14. $QCOM: -3.0% | +96% ByteDance AI customer. On-device AI just unlocked a new TAM. 15. $ASTS: -6.6% | +295% Satellite-to-smartphone broadband. 3 billion potential subscribers. 16. $IONQ: -1.7% | +146% Trapped-ion quantum. Defense contracts validating the commercial roadmap. 17. $RKLB: -4.0% | +355% SpaceX IPO lifts all space boats. Neutron rocket = the next growth engine. 18. $NBIS: -8.4% | +459% Jensen Huang's neocloud pick. Leopold Aschenbrenner's top holding. AI infra pure play. 19. $IREN: -5.5% | +598% $3.65B GPU financing. Microsoft deal. AI cloud pivot fully underway. 20. $LITE: -8.6% | +975% $NVDA invested $6.5B in photonics. LITE is the picks-and-shovels winner. DO NOT MISS this dip opportunity, you don't have to be a genius to be a millionaire by 2030. ♻️ RESHARE this post and write 1 comment, I'll DM you my favorite 5 stocks to buy to 10x my portfolio.

This rule has proven success, & will guarantee your portfolio to outperform the S&P 500 year after year… Buy stocks when $VIX is $30. Buy even more stocks when $VIX is above $45+ Sell stocks when $VIX is $14. & simply repeat the cycle!